KyraMed Biomol Naturprodukte GmbH
Pharmaceutical Companies · Gießen
KyraMed Biomol Naturprodukte GmbH is a pharmaceutical company based in Gießen, Hesse, Germany. The company operates in the German pharmaceutical market and is regulated by the BfArM (Federal Institute for Drugs and Medical Devices).
Content in German
The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.
Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.
KyraMed Biomol Naturprodukte GmbH – Address & Contact
KyraMed Biomol Naturprodukte GmbH Overview
KyraMed Biomol Naturprodukte GmbH is a pharmaceutical company based in Gießen, Hessen. The company operates in the German pharmaceutical market and is regulated by the BfArM (Federal Institute for Drugs and Medical Devices).
Activities & Products
Pharmaceutical companies such as KyraMed Biomol Naturprodukte GmbH develop, produce or distribute medicines for the German and international market. All authorised products are subject to approval and are regulated by BfArM or the European Medicines Agency (EMA).
Location & Contact
KyraMed Biomol Naturprodukte GmbH can be reached at the following address: Waldstr. 67b, 35440 Gießen – Phone: 06403940028. For current information and enquiries, please contact the company directly.
More information: Pharmaunternehmen in Hessen or all Pharmaunternehmen in Germany on Sanoliste.
Pharmazeutische Regulierung in Deutschland
Pharmaceutical companies such as KyraMed Biomol Naturprodukte GmbH are subject to one of the world's most stringent regulatory frameworks in Germany. The German Medicinal Products Act (AMG) governs the authorisation, manufacturing, distribution and monitoring of medicinal products. Market authorisation for new active substances falls under the responsibility of either the Federal Institute for Drugs and Medical Devices (BfArM) or the European Medicines Agency (EMA), depending on whether a national or centralised authorisation is sought.
Arzneimittelversorgung & Marktumfeld
With a revenue volume exceeding 50 billion euros, the German pharmaceutical market is one of the largest in Europe. KyraMed Biomol Naturprodukte GmbH, based in Gießen, is part of this market. The supply chain from manufacturer through wholesaler to pharmacy is governed by Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP). Since the entry into force of the Act for Greater Safety in the Medicinal Products Supply (GSAV), stricter requirements for the traceability of medicinal products also apply.
Pharmastandort Hessen
Hessen is a significant pharmaceutical location in Germany. Companies such as KyraMed Biomol Naturprodukte GmbH benefit from proximity to research institutions, university hospitals and well-developed infrastructure. The industry employs over 140,000 people in Germany and invests billions annually in research and development.
Frequently asked questions about KyraMed Biomol Naturprodukte GmbH
What does KyraMed Biomol Naturprodukte GmbH do?
KyraMed Biomol Naturprodukte GmbH hat sich als Pharmaundernehmen on the ganzheitliche Gesandheit fokussiert. Für the Haut gibt es ein Drei-Säulen-Therapie-Konzept, the at Neurorwithis and Ekzemen eingesetzt are kann. Weiter is ein Omega-3-Pulver im range for Leisungssteigerung im Alltag and ein Mittel at Nierenerkrankungen.
What medicines does KyraMed Biomol Naturprodukte GmbH manufacture?
KyraMed Biomol Naturprodukte GmbH is a pharmaceutical company in Gießen. Über KyraMed Biomol Naturprodukte GmbH KyraMed Biomol Naturprodukte GmbH is ein renommiertes company, the sich on the research, development and manufacturing of Gesandheitsp Alle in Germany zugelassenen medicines are in the medicines-Datenbank des BfArM recherchierbar.
How are medicines approved in Germany?
Neue medicines benötigen vor dem Inverkehrbringen eine Zulassung durch the BfArM (national) or the EMA (europaweit). Der Zulassungsprozess umfasst the Prüfung of quality, Wirksamkeit and Unbedenklichkeit on Basis präklinischer and klinischer Stuthen. Die Nutzenbewertung after § 35a SGB V entscheidet about the Erstattung durch the gesetzlichen Krankenkassen.
What does GMP mean in pharmaceutical production?
GMP (Good Manufacturing Practice) bezeichnet the Gute manufacturingspraxis – ein System of qualitysstandards, the sicherstellt, thes medicines gleichbleibend after den gefortheten qualitysnormen hergestellt and geprüft are. Die GMP-Richtlinien are in the EU durch den EudraLex Volume 4 definiert.
More Pharmaceutical Companies in Gießen
Pharmaceutical Companies in Germany
Related areas in healthcare
Pharmaceutical Companies in Hessen
All Pharmaceutical Companies in Hessen on Sanoliste — or discover all categories by federal state.